Benchmark upgraded Nephros to Speculative Buy from Hold with a $5 price target after the company reported “solid” results for Q4 and 2023 as a whole. The firm, which forecasts that Nephros will post revenues of $17.1M, up 20% year-over-year in FY24, sees a “positive outlook and quarterly comparisons going forward.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NEPH:
- Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results
- Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results
- Nephros, Inc. (NEPH) Q4 Earnings Cheat Sheet
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue